Digital insomnia treatment in Australian pharmacy settings.

Not Applicable

Recruiting

• Conditions: Insomnia disorder; Mental Health - Other mental health disorders; Neurological - Other neurological disorders

• Registration Number: ACTRN12624000311550
• Lead Sponsor: The Adelaide Institute for Sleep Health, Flinders University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-03-22
• Last Update Posted: 24 June 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Pharmacist inclusion criteria:
1. Currently practicing as a pharmacist in Australia.

Patient inclusion criteria:
1. Aged at least 18
2. Referred by participating pharmacist.
3. Reliable access to computer, tablet or smartphone, with internet access.
4. Basic English language comprehension as required for dCBTi program participation.

Exclusion Criteria

1. No excessive daytime sleepiness (Epworth Sleepiness Scale score score of greater than or equal to 16).
2. None of the following psychiatric conditions; Bi-polar disorder, schizophrenia.
3. No risk of suicide (PHQ-9; item 9 score of greater than or equal to 1).
4. No Epilepsy.
5. Not currently pregnant.
6. No commercial drivers or people who operate heavy machinery for work.
7. No people with a cognitive impairment.
8. No shift-workers.
9. Previous sleepiness-related motor vehicle accident.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rate of pharmacist recruitment.[Number of pharmacists providing informed consent to participate and access the digital CBTi referral pathway, accessed via study records. Study-level outcome:<br>Assessed at conclusion of the study.];Patient-level outcome: <br>Between-group difference in self-reported insomnia severity on the Insomnia Severity Index (ISI) questionnaire.[Insomnia Severity Index (ISI) 8-week follow-up.]